MNSO heads into August earnings with short sellers adding aggressively and a borrow market that has swung from severely tight to merely firm — a setup that bears watching for anyone with conviction either way.
The sharpest development this week is how quickly shorts have rebuilt. Estimated short interest jumped roughly 40% in a single week — from around 2.1 million shares to nearly 3.0 million — and is up 54% over the past month. The pace of that rebuild is notable on its own. More interesting still is the context: just three weeks ago, availability was near rock-bottom, with fewer than one share available per ten already borrowed. That extreme tightness appears to have eased as new supply entered the lending pool. Availability now sits around 58%, meaning the borrow market is tight but no longer rationed. Cost to borrow, at 3.6%, has drifted down from its June highs above 6% even as short demand surged — a sign that the fresh supply arrived at the right moment. The ORTEX short score has responded accordingly, climbing from around 55 to 59.5 over the past week, its highest reading in the sample window.
Options positioning pulls in a different direction. Call positioning is running well ahead of puts — the put/call ratio is 0.34, below its 20-day average of 0.38, and at roughly half the levels seen as recently as mid-June when it was touching 0.55-0.57. That's a notably bullish tilt in options. The divergence between a surging short interest number and call-heavy options flow is the clearest tension on this stock right now. One of those camps has mispriced the August 24 earnings setup.
The Street backdrop makes the picture no easier to read. The consensus sits at buy, with twelve analysts holding that view. But the most recent material move came from JP Morgan in late May, when Kevin Yin slashed his price target from $26 to $16 while keeping an Overweight rating — a cut of nearly 40% that came right after the last earnings print, which sent the stock down almost 8% in a single session. The gap between JP Morgan's $16 target and the current $11.53 price implies residual upside even in the most recently reset target, but the distance from the consensus mean of roughly $135 (flagged here only as a data artifact — this almost certainly reflects stale or currency-mismatched inputs from other listing structures and should not be taken at face value) renders the aggregated price target unreliable. The valuation tells the more honest story: MNSO trades at about 7.5x trailing earnings and 5.1x EV/EBITDA, both multiples that have compressed roughly 10% over the past month. The factor scoring adds a layer of nuance — the company ranks in the 97th percentile on EPS surprise and 84th on forward earnings growth, but the short score ranks in just the 15th percentile, meaning shorts are positioned more aggressively than for most peers.
Founder and controlling shareholder Guofu Ye holds 66% of shares outstanding, with Norges Bank the largest external institutional holder at 5.2%. Millennium Management added aggressively in Q1, picking up around 349,000 shares. The concentrated founder ownership means that any secondary supply or change in that position would move the stock materially — but there's no signal of that here.
The prior two earnings reactions have been negative: a 7.8% drop in May and a 5.7% drop in the preceding print. With the next report scheduled for August 24, the setup entering that date — how the borrow market evolves, whether short interest continues to build or plateaus, and whether the call-heavy options positioning gets unwound — is the central question for MNSO between now and then.
See the live data behind this article on ORTEX.
Open MNSO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
